« Return to News | Awards & Advancement

LabConnect Hires Former Quintiles Exec to be COO

Friday, August 28, 2009 07:32 AM

LabConnect, a provider of central laboratory services to the clinical trial industry, appointed former Quintiles executive Frank Morrow, Ph.D., as its chief operating officer.

Morrow was founding executive, president and chief scientific officer at Quintiles Laboratories Worldwide before joining LabConnect. According to LabConnect, he was responsible for growing Quintiles’ lab from inception to $120 million in revenue, 1,000 employees and five worldwide central lab facilities.

Elsewhere in the clinical trial industry, ICON named Alan Marion, M.D., Ph.D., vice president and medical director of the contract research organization’s (CRO’s) new clinical pharmacology unit in Omaha, Neb. Prior to joining ICON, Marion was principal investigator at MDS Pharma Services.

CRO Health Decisions hired Craig Hurt as its new controller to “prime” the company for growth, according to Health Decisions’ chief financial officer, Alicia Paladin. Hurt, a licensed CPA, will manage all accounting and finance functions, including compliance with GAAP and regulatory authorities, for the CRO. He was formerly senior finance manager at Nortel.

Former INC Research and PPD executive Becky Causey has been named executive vice president of clinical operations for ResearchPoint. In this role, Causey will assist in defining processes and strategic direction for operations for the CRO.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.